A detector's eye view (DEV)-based OSEM algorithm for benchtop x-ray fluorescence computed tomography (XFCT) image reconstruction.

In this study, we developed a detector's eye view (DEV)-based ordered subsets expectation maximization (OSEM) algorithm for more accurate reconstruction of benchtop x-ray fluorescence computed tomography (XFCT) images. The proposed approach was tested using two sets of benchtop XFCT imaging data derived from a newly performed gold nanoparticle (GNP)-containing phantom imaging study and a previously published postmortem benchtop XFCT imaging study of a tumor-bearing mouse injected with GNPs. DEV-based OSEM resulted in higher spatial resolution (up to ~20% decrease in the full width at half maximum values of the regions of interest), compared with filtered back-projection (FBP) and traditional OSEM. It also resulted in up to an order of magnitude smaller background noise in the reconstructed images than FBP, while producing consistently less background noise than traditional OSEM.

Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles.

Theoretical investigations suggest that gold nanoparticle (GNP)-mediated radiation dose enhancement and radiosensitization can be maximized when photons interact with gold, predominantly via photoelectric absorption. This makes ytterbium (Yb)-169, which emits photons with an average energy of 93 keV (just above the K-edge of gold), an ideal radioisotope for such purposes. This investigation tests the feasibility of tumor-specific prostate brachytherapy achievable with Yb-169 and actively targeted GNPs, using an external beam surrogate of Yb-169 created from an exotic filter material - erbium (Er) and a standard copper-filtered 250 kVp beam. The current in vitro study shows that treatment of prostate cancer cells with goserelin-conjugated gold nanorods (gGNRs) promotes gonadotropin releasing hormone receptor-mediated internalization and enhances radiosensitivity to both Er-filtered and standard 250 kVp beams, 14 and 10%, respectively. While the degree of GNP-mediated radiosensitization as seen from the in vitro study may be considered moderate, the current in vivo study shows that gGNR treatment plus Er-filtered x-ray irradiation is considerably more effective than radiation treatment alone (p < 0.0005), resulting in a striking reduction in tumor volume (50% smaller) 2 months following treatment. Overall, the current results provide strong evidence for the feasibility of tumor-specific prostate brachytherapy with Yb-169 and gGNRs.